November 28, 2025

Personalis, Inc. (PSNL) Stock Analysis: Navigating Challenges with Strategic Collaborations and Innovative Genomic Solutions

Personalis, Inc. (NASDAQ: PSNL) stands at a critical juncture, with its current stock price at $10.72 and a 52-week range spanning from $3.00 to a high of $11.21. Operating within..

Nutex Health Inc. (NUTX) Investor Outlook: Analyzing the 239.90% Revenue Growth and 121.63% Upside Potential

Nutex Health Inc. (NUTX), a dynamic player in the healthcare sector, is catching the attention of investors with its impressive 239.90% revenue growth and a noteworthy potential upside of 121.63%...

Cullinan Therapeutics, Inc. (CGEM) Investor Outlook: Unraveling a 129.98% Potential Upside

Cullinan Therapeutics, Inc. (NASDAQ: CGEM), a clinical-stage biopharmaceutical company, stands at an intriguing crossroads for investors, presenting a compelling opportunity with substantial potential upside. Specializing in therapies for autoimmune diseases..

Bicycle Therapeutics plc (BCYC) Stock Analysis: Unveiling a 184.79% Potential Upside

Bicycle Therapeutics plc (NASDAQ: BCYC), a pioneer in the biotechnology sector, is capturing investor attention with an impressive potential upside of 184.79%. As a clinical-stage pharmaceutical company based in Cambridge,..

Bicara Therapeutics Inc. (BCAX) Stock Analysis: Exploring a 71% Upside in the Biotech Sector

Bicara Therapeutics Inc. (BCAX), a burgeoning player in the biotechnology industry, has captured the attention of investors with its potential for significant upside. As a clinical-stage biopharmaceutical company, Bicara is..

Maravai LifeSciences Holdings (MRVI) Stock Analysis: Navigating Growth Amid a Challenging Landscape

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a key player in the biotechnology sector, presents a captivating case for investors who are keen on exploring opportunities in the healthcare industry. With..

Delcath Systems, Inc. (DCTH) Stock Analysis: A Closer Look at Its 131% Potential Upside

Delcath Systems, Inc. (NASDAQ: DCTH) has been drawing significant attention in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $340.42 million, the company primarily..

Enhabit, Inc. (EHAB) Stock Analysis: Assessing Growth Potential Amidst a 5.20% Upside

Enhabit, Inc. (NASDAQ: EHAB), a prominent player in the healthcare sector, specializes in providing essential home health and hospice services across the United States. With a current market capitalization of..

Kura Oncology, Inc. (KURA): Investor Outlook Reveals a Striking 175% Potential Upside

Kura Oncology, Inc. (NASDAQ: KURA), a promising player in the biotechnology sector, is drawing significant attention from investors with its potential for substantial upside. Specializing in the development of innovative..

Semler Scientific Inc. (SMLR) Stock Analysis: A 217% Potential Upside That Intrigues Investors

Semler Scientific, Inc. (NASDAQ: SMLR) is capturing the attention of investors with a tantalizing potential upside of 217.54%, based on analyst ratings. This healthcare-sector company, specializing in medical devices, offers..

A shift in how IoT is secured by default

KeyScaler 2025 transforms IoT security by automating trust across every device’s lifecycle, from onboarding to decommissioning, turning scalable connectivity and compliance into a built-in feature...

Stoke Therapeutics, Inc. (STOK) Stock Analysis: Strong Buy Ratings and Impressive Revenue Growth Highlight Growth Potential

Stoke Therapeutics, Inc. (NASDAQ: STOK), a promising player in the biotechnology sector, has caught the attention of investors with its innovative approach to tackling severe genetic diseases. Headquartered in Bedford,..

Investor Outlook: Arvinas, Inc. (ARVN) Navigates Challenges with Cutting-Edge Biotech Innovation

Arvinas, Inc. (NASDAQ: ARVN), a clinical-stage biotechnology firm from New Haven, Connecticut, is at the forefront of an innovative wave in healthcare, leveraging PROTAC technology to tackle disease-causing proteins. Despite..

REGENXBIO Inc. (RGNX) Stock Analysis: A Biotech with 122.82% Potential Upside and Promising Clinical Pipeline

REGENXBIO Inc. (NASDAQ: RGNX) stands out in the biotechnology sector, showcasing a robust growth potential that has caught the attention of investors. With a market capitalization of $671.26 million, this..

Butterfly Network, Inc. (BFLY) Stock Analysis: A Promising Upside of 27% in the Medical Device Arena

For investors with a keen eye on the healthcare sector, Butterfly Network, Inc. (NYSE: BFLY) offers a compelling prospect in the medical devices industry. Known for its innovative ultrasound imaging..

Ginkgo Bioworks Holdings, Inc. (DNA) Investor Outlook: Analyzing a 17% Potential Upside Amidst Market Challenges

Ginkgo Bioworks Holdings, Inc. (NASDAQ: DNA) presents a complex yet intriguing proposition for investors navigating the ever-evolving biotechnology sector. As a prominent player in the realm of cell programming, Ginkgo..

Auna SA (AUNA) Stock Analysis: High Potential Upside with 123% Target Growth

Auna S.A. (AUNA), a healthcare service provider headquartered in Luxembourg, presents an intriguing opportunity for investors with its remarkable potential upside. Operating hospitals and clinics in Mexico, Peru, and Colombia,..

Orthofix Medical Inc. (OFIX) Stock Analysis: 41% Potential Upside Beckons Investors

Orthofix Medical Inc. (NASDAQ: OFIX), a prominent player in the healthcare sector specializing in medical devices, presents a compelling opportunity for investors with a potential upside of 41.26%. This intriguing..

Evolus, Inc. (EOLS) Investor Outlook: Unveiling a 165% Potential Upside in the Performance Beauty Sector

Evolus, Inc. (NASDAQ: EOLS) is capturing investor attention with its significant potential upside of over 165%, presenting a compelling case for those looking to invest in the performance beauty sector...

Valneva SE (VALN) Stock Analysis: Exploring a 20% Potential Upside in the Biotech Sector

Valneva SE (NASDAQ: VALN), a prominent player in the biotechnology industry, has been capturing investor attention with its focus on developing vaccines for infectious diseases with unmet needs. Based in..

Search

Funds

November 28, 2025

A shift in how IoT is secured by default

KeyScaler 2025 transforms IoT security by automating trust across every device’s lifecycle, from onboarding to decommissioning, turning scalable connectivity and compliance into a built-in feature...
Search

Funds

November 28, 2025

FTSE 100

Funds